Teo_Dagi

MD, DMedSci, DHC, FRCSEd MBA

Chairman

Dr. Dagi is CEO of Boston Neurosciences, Inc., a non-invasive brain monitoring company. His interests are focused on biomedical innovation, patient safety and effectiveness in healthcare delivery. He serves as Managing Partner at the Salutramed Group, an Atlanta-based life-sciences consulting firm, and director of life sciences for Anglo Scientific at the Royal Institution in London.

Teo trained as a neurosurgeon at the Massachusetts General Hospital, and worked in the Laboratory for Cerebral Metabolism at the NIH. He served as a neurosurgeon and flight surgeon at the Walter Reed Army Medical Center, and Section Chief at Brown University, and then practiced in Atlanta where he held faculty appointments at the Georgia Institute of Technology and the Medical College of Georgia. At the same time, he became a partner in a venture capital firm, where he led investments in the life sciences, medical informatics and biomedical technologies. He has served as a director of public and private companies and presided over scientific advisory boards for DuPont, Lunbeck (USA), the Royal Bank of Canada and other entities. He is also a director of the Anesthesia Patient Safety Foundation and an overseer of the Beth Israel Deaconess Medical Center. He is the immediate past chair of the Committee on Perioperative Care of the American College of Surgeons and the Council on Surgical and Perioperative Safety.

Teo is former chair of the Georgia Neurosurgical Society, and former director of the American Association of Neurological Surgeons, the Georgia Institute of Technology, the Wharton School of the University of Pennsylvania, the Georgia Biomedical Alliance, the Southeast Lifesciences Investor Association, and the Georgia Entrepreneur Foundation. He advises CURAM, the medical device initiative of the National University of Ireland in Galway. He was a medical advisor to the Office of Technology Assessment of the Congress of the United States and served at the FDA on the panel for neurological drugs and devices. He has advised sovereign governments, states and universities on life science and biomedical investment and innovation initiatives.

Teo has held academic appointments at Harvard Medical School and Queen’s University Belfast, where he chaired the advisory panel for the School of Medicine and, currently chairs the advisory panel for the School of Management. He serves on the faculty of the NVCA’s Venture Capital Institute and has lectured on innovation in health care at Harvard Business School. He has authored or edited eight books and over 150 articles and chapters. He received an AB from Columbia College, MD and MPH from Johns Hopkins, MBA from Wharton, the DMedSc from Queen’s University Belfast, and a DHC from the Kaunas Technical Institute in Lithuania

Dr. Dagi is board certified in neurological surgery. For his work in international disaster assistance, he was awarded the US Humanitarian Service Medal and Fellowship in the College of Critical Care Medicine. He was granted Fellowship ad hominem by the Royal College of Surgeons of Edinburgh.